Description
Biogenic Pharma Stenabolic (SR9009) is a research compound developed by Professor Thomas Burris at The Scripps Research Institute. While often marketed as a Selective Androgen Receptor Modulator (SARM), technically, SR9009 is not a SARM. Instead, it is a Rev-ErbA agonist, meaning it binds to the Rev-ErbA protein in the body, influencing circadian rhythm, metabolism, and fat-burning processes.
Biogenic Pharma is one of several underground or research chemical suppliers that produce and sell Stenabolic in capsule or liquid form for research purposes only.
How Stenabolic (SR9009) Works
SR9009 activates Rev-ErbA proteins, which play a role in:
-
Regulating circadian rhythm (internal biological clock)
-
Increasing mitochondrial activity for greater energy production
-
Enhancing fat metabolism and glucose regulation
-
Reducing cholesterol and triglycerides in some studies
This makes it appealing to bodybuilders, athletes, and fitness enthusiasts looking for fat loss, endurance, and performance improvements.
Benefits of Biogenic Pharma Stenabolic (SR9009)
While human clinical studies are lacking, animal and anecdotal evidence suggest:
-
Enhanced endurance – sometimes referred to as “exercise in a pill”
-
Improved fat burning and weight management
-
Better energy levels and stamina during training
-
Reduced cholesterol and improved lipid profile
-
Increased metabolism even while at rest
Dosage and Cycle (Research Data)
⚠️ Important: SR9009 is not FDA-approved for human consumption. The following is based on research and user reports:
-
Typical Range: 10–30 mg per day, often split into multiple doses due to its short half-life (~4–6 hours).
-
Cycle Length: 6–8 weeks, sometimes extended depending on goals.
-
Stacking: Often combined with other SARMs or fat-burners for synergistic results.
Reviews
There are no reviews yet.